Skip to main content
Log in

The tale in evolution: clarity, consistency and consultation, not contradiction and confusion

  • Published:
Pituitary Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ho KKY, Fleseriu M, Wass J et al (2019) A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement. Pituitary 22(6):569–573

    Article  PubMed  Google Scholar 

  2. Asa SL, Asioli S, Bozkurt S et al (2019) Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution. Pituitary. https://doi.org/10.1007/s11102-019-01015-0

    Article  Google Scholar 

  3. Asa SL, Casar-Borota O, Chanson P et al (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24(4):C5–C8

    Article  CAS  PubMed  Google Scholar 

  4. Asioli S, Righi A, Iommi M et al (2019) Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur J Endocrinol 180(2):127–134

    Article  CAS  PubMed  Google Scholar 

  5. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege Belgium. J Clin Endocrinol Metab 91(12):4769–4775

    Article  CAS  PubMed  Google Scholar 

  6. Tampourlou M, Ntali G, Ahmed S et al (2017) Outcome of nonfunctioning pituitary adenomas that regrow after primary treatment: a study from two large UK centers. J Clin Endocrinol Metab 102(6):1889–1897

    Article  PubMed  Google Scholar 

  7. Atkinson H, England JA, Rafferty A et al (2013) Somatostatin receptor expression in thyroid disease. Int J Exp Pathol 94(3):226–229

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Forssell-Aronsson EB, Nilsson O, Benjegard SA et al (1111n) 1111n-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors. J Nucl Med 41:636–642

    CAS  PubMed  Google Scholar 

  9. Pisarek H, Stepien T, Kubiak R, Pawlikowski M (2008) Somatostatin receptors in human adrenal gland tumors–immunohistochemical study. Folia Histochem Cytobiol 46(3):345–351

    Article  PubMed  Google Scholar 

  10. Mariniello B, Finco I, Sartorato P et al (2011) Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells. J Endocrinol Invest 34(6):e131

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This statement received no funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ken K. Y. Ho.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Research involving human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ho, K.K.Y., Fleseriu, M., Wass, J. et al. The tale in evolution: clarity, consistency and consultation, not contradiction and confusion. Pituitary 23, 476–477 (2020). https://doi.org/10.1007/s11102-019-01027-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-019-01027-w

Navigation